As diabetes, cardiovascular conditions, respiratory disorders, and other long-duration illnesses become more common, care delivery is shifting from episodic checkups to continuous observation, increasing demand for the ehealth devices market. Providers and payers increasingly use connected glucose monitors, blood pressure devices, pulse oximeters, ECG wearables, and similar tools to track patients between visits, identify deterioration earlier, and reduce avoidable hospital utilization. This changes purchasing behavior in the ehealth devices market by favoring devices that support frequent data capture, reliable connectivity, and clinician-facing dashboards, while also increasing market penetration in home-based care models where long-term disease management depends on routine remote monitoring rather than in-person supervision.
Integration of IoT and AI enabling connected home healthcare monitoring ecosystems
The combination of IoT connectivity and AI-based analytics is moving the ehealth devices market beyond standalone instruments toward interoperable home monitoring environments that continuously collect, transmit, and interpret patient data. In practice, connected devices feed real-time readings into apps, cloud platforms, and provider systems, while AI helps prioritize alerts, detect patterns, and reduce the burden of reviewing large volumes of routine measurements. This strengthens market development by making eHealth devices more useful in daily care management, encouraging health systems and consumers to adopt device portfolios that work together as part of a coordinated home healthcare ecosystem rather than as isolated monitoring products.
Growing government digital health initiatives improving accessibility of eHealth monitoring devices
Public-sector digital health programs are improving the conditions for wider adoption in the ehealth devices market by supporting telehealth infrastructure, electronic health record integration, remote care pathways, and broader digital access. When governments promote connected care delivery, establish digital health frameworks, or fund virtual care expansion, eHealth monitoring devices become easier to prescribe, deploy, and incorporate into routine clinical workflows. This supports market expansion by lowering practical barriers to use, especially in underserved or geographically dispersed populations where device-enabled monitoring can extend care reach without requiring the same level of physical healthcare infrastructure.
| Growth Driver Assessment Framework | |||||
| Growth Driver | Impact On CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising chronic diseases prevalence driving continuous remote patient monitoring device adoption globally | 2.30% | Moderate | North America, Europe, Asia Pacific | High | Near Term |
| Integration of IoT and AI enabling connected home healthcare monitoring ecosystems | 2.00% | Moderate | North America, Europe, Asia Pacific | High | Mid Term |
| Growing government digital health initiatives improving accessibility of eHealth monitoring devices | 1.60% | High | Asia Pacific, Latin America | Medium | Mid Term |
North America held a 41.34% share of the ehealth devices market in 2025, supported by broad deployment of connected care infrastructure across hospitals, clinics, and home-based monitoring settings. The region’s leadership is sustained by strong integration of digital health tools into routine care delivery, where providers use remote monitoring devices, wearable trackers, and connected diagnostic systems to manage chronic conditions, post-acute follow-up, and patient engagement more efficiently. Market activity is further reinforced by high device adoption among consumers and care organizations that are already accustomed to data-driven health management workflows.
Asia Pacific is projected to expand at a 10.74% CAGR over the forecast period in the ehealth devices market, driven by accelerating adoption of digital healthcare tools across large and increasingly connected patient populations. Growth is being fueled by the practical need to extend care access beyond traditional clinical settings, which is increasing demand for portable monitoring devices, app-linked wearables, and remote health management solutions. As healthcare systems and users in the region incorporate connected devices more actively into everyday care and wellness tracking, uptake is rising across both medical and consumer-facing use cases.
| Regional Market Attractiveness & Strategic Fit Matrix | |||||
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub | Advanced | Developing | Advanced | Nascent | Nascent |
| Cost-Sensitive Region | Medium | High | Medium | High | High |
| Regulatory Environment | Supportive | Restrictive | Restrictive | Neutral | Neutral |
| Demand Drivers | Strong | Moderate | Strong | Weak | Weak |
| Development Stage | Developed | Developing | Developed | Emerging | Emerging |
| Adoption Rate | High | Medium | High | Low | Low |
| New Entrants / Startups | Dense | Moderate | Dense | Sparse | Sparse |
| Macro Indicators | Strong | Stable | Stable | Weak | Weak |
The U.S. ehealth devices market is advancing through broader adoption of remote patient monitoring and connected wearable technologies. Healthcare providers are increasingly integrating device-generated data into care pathways to improve chronic disease management and patient engagement.
Japan is deploying ehealth devices to address healthcare needs associated with an aging population and rising demand for home-based care. The market favors user-friendly monitoring technologies that enable continuous health tracking and reduce pressure on care facilities.
South Korea is integrating ehealth devices with advanced mobile health platforms and telemedicine services. Consumers and healthcare providers in South Korea are increasingly adopting connected devices that support preventive care and real-time health monitoring.
Germany is strengthening the use of ehealth devices through digital healthcare initiatives and reimbursement support for remote monitoring. Demand in Germany is centered on clinically validated devices that can securely connect with healthcare information systems.
France is emphasizing ehealth devices that facilitate chronic disease management and preventive healthcare programs. Regulatory attention on digital health solutions is encouraging adoption of connected monitoring tools across both clinical and home-care environments.
Italy is seeing increased demand for ehealth devices that support remote monitoring and decentralized healthcare delivery. Healthcare organizations in Italy are focusing on technologies that improve patient follow-up and extend care services beyond traditional clinical settings.
Glucose Meters held a 36.04% share of the ehealth devices market in 2025, making them the leading product type within this segment. Their position is sustained by the routine and frequent monitoring needs associated with diabetes management, which creates steady device usage across homecare and clinical settings. In the ehealth devices market, glucose meters benefit from well-established patient familiarity, recurring testing behavior, and strong relevance in day-to-day chronic disease tracking, all of which help preserve their leading share.
Blood Pressure Meters are emerging as the fastest-growing segment in the ehealth devices market as monitoring expands beyond clinical environments into regular home-based use. Their momentum is aided by rising demand for convenient cardiovascular tracking and the practical value of frequent blood pressure measurement for ongoing health management. Compared with alternatives that are often tied to condition-specific testing routines, blood pressure meters are gaining wider adoption because they align well with preventive care habits and connected remote monitoring workflows.
| Report Segmentation | |||
| Segment | Sub-Segment | Largest Segment | Fastest Growing Segment |
|---|---|---|---|
| Type | Blood Pressure Meters, Fever Meters, Glucose Meters, Care Phone/Social Alarms | Glucose Meters | Blood Pressure Meters |
1. Abbott Laboratories (United States)
2. Medtronic plc (Ireland)
3. DexCom Inc. (United States)
4. Omron Corporation (Japan)
5. F. Hoffmann-La Roche AG (Switzerland)
6. PHC Holdings Corporation (Japan)
7. Doro AB (Sweden)
8. Koninklijke Philips N.V. (Netherlands)
Digital health monitoring is becoming more integrated with connected care ecosystems. Real-time health tracking and analytics are improving preventive healthcare outcomes. The ehealth devices market is advancing through intelligent wearable and remote monitoring technologies.
| Company Name | Date | Key Development |
|---|---|---|
| Koninklijke Philips N.V. | Sep-25 | Philips launched a smart telemetry platform for cardiac monitoring designed to enable continuous patient connectivity beyond bedside environments. The development strengthens remote patient monitoring infrastructure and expands clinical data continuity, supporting broader adoption of connected healthcare systems and improving real-time monitoring capabilities across care settings. |
| Koninklijke Philips N.V. | Sep-25 | Philips and Masimo Corporation renewed their innovation partnership to integrate advanced patient monitoring technologies into Philips’ platforms. The collaboration enhances access to physiological measurement capabilities and strengthens interoperability across monitoring systems, reinforcing the ecosystem for advanced hospital and remote patient care solutions. |
| Oracle | Aug-25 | Oracle launched a next-generation AI-driven Oracle Health EHR built on Oracle Cloud Infrastructure. The system is designed to reduce administrative burden and improve clinical workflow intelligence, strengthening digital healthcare infrastructure and enhancing data-driven decision-making capabilities within electronic health record systems. |
| Athenahealth | Aug-25 | Athenahealth introduced major upgrades to its athenaOne platform focused on AI-enabled interoperability and enhanced data exchange. The development improves clinical insights and workflow efficiency for ambulatory care providers, strengthening connectivity across healthcare data systems and supporting broader digital transformation in eHealth platforms. |
| Surescripts | Feb-25 | Surescripts launched Touchless Prior Authorization technology to streamline ePrescribing workflows and reduce administrative delays. The solution enhances automation in payer-provider interactions, improving efficiency in medication approval processes and strengthening digital infrastructure supporting prescription management systems. |
| Cerner Corporation | Jan-19 | Cerner Corporation collaborated with ResMed to integrate Brightree Home Health and Hospice platform with Cerner Millennium EHR. The initiative strengthens interoperability between hospital systems and home care providers, improving continuity of care and enabling more integrated healthcare data exchange across care delivery settings. |
| Allscripts | Oct-19 | Allscripts entered an agreement with Northwell Health to jointly develop an AI-powered next-generation electronic health record system. The collaboration focuses on enhancing clinical decision support and improving data intelligence within EHR systems, strengthening digital healthcare infrastructure and workflow optimization. |
The market size of ehealth devices in 2026 is calculated to be USD 22.25 billion.
eHealth Devices Market size is set to grow from USD 20.55 billion in 2025 to USD 50.93 billion by 2035 reflecting a CAGR greater than 9.5% through 2026-2035.
Rising chronic disease management needs are increasing demand for connected monitoring devices that support continuous home-based care. Healthcare providers increasingly prioritize solutions offering reliable data capture, clinician integration, and routine remote monitoring capabilities.
IoT connectivity and AI analytics transform standalone devices into integrated monitoring ecosystems by enabling real-time data sharing, intelligent alerts, and coordinated care management, encouraging broader adoption by healthcare providers and consumers.
Glucose meters lead with a 36.04% share due to routine diabetes monitoring needs, frequent testing behavior, and strong integration into both homecare and clinical chronic disease management workflows.
Blood pressure meters are the fastest-growing segment as consumers adopt regular at-home cardiovascular monitoring, supported by preventive care trends and expanding use of connected remote health tracking systems.
North America captured 41.34% of the market in 2025 due to widespread connected healthcare infrastructure, strong remote monitoring adoption, and extensive use of digital health tools across care settings.
Asia Pacific is expected to grow at a 10.74% CAGR, driven by expanding digital healthcare access, increasing demand for portable monitoring devices, and broader adoption of connected health solutions.
Leading companies in the ehealth devices market include Abbott Laboratories (United States), Medtronic plc (Ireland), DexCom, Inc. (United States), Omron Corporation (Japan), F. Hoffmann-La Roche AG (Switzerland), PHC Holdings Corporation (Japan), Doro AB (Sweden), Koninklijke Philips N.V. (Netherlands).